Monoclonal Antibody Based Products - Global Trends

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.GLOBAL MARKET OVERVIEW AND OUTLOOK
MAb Market – Set for Significant Growth
Therapeutic mAb Market – Principal Driving Force
Development of New MAbs on a Fast Track
Genomics Research Leads Way to New Monoclonal Antibodies
Bright Outlook for Mabs
Current and Future Analysis
Product Segment Perspective
Competitive Scenario
Intensifying Consolidation Activity
Drug Developers Trying to Break the Shackles
Rituximab Vs. Epratuzumab
A Revolution Not too Far…
Milestones in Development of MAbs
Focus on Unmet Medical Needs in the Emerging Markets
3.TRENDS AND ISSUES
Shift Towards Humanized and Fully Human Antibodies
Ageing Baby Boomers Spur MAbs Growth
Non-Existent Generic Competition Favors MAb Market
Partnerships and Collaborations Spark Increase in Profit Margins
Pharma Majors & CMOs Augment Investment in Mab Production
Rising Number of MAbs Under Clinical Trials
Select Clinical Trials for Monoclonal Antibodies
Major Monoclonal Antibodies in Phase III Trials Across the World
High Costs Impede MAbs Penetration
Opportunities in Technology Development
Advancements & Challenges in Antibody Production Processes
Increasing Demand for Protein A in Mab Manufacturing
FCA- A Major Cause for Discomfort in Mice
Innovations to Drive Growth in Anti-Ovarian Cancer Drugs Market
Rising Incidence of NHL to Drive Monoclonal Antibody Drug Market
4.PRODUCT FACTS
A. Therapeutics
Cancer
Other Therapeutic Mabs
B. Diagnostics
Types of Monoclonal Antibodies
5.CORPORATE DEVELOPMENTS
Callisto Merger Corporation Merges with Celldex Therapeutics
SDI to Develop mAbs for SAIC-F and NCI
HGS Reacquires Rights for TRAIL Receptor Antibodies
Amgen Enters into Licensing Agreement with Kyowa Hakko
Dyax and Sanofi-Aventis Sign Agreements
HGS Enters into Antibody Collaboration Agreement with Xencor
Amgen Introduces Vectibix
UCB Receives FDA Approval for Cimzia®
Genentech Acquires Tanox
Biotest Acquires Assets of Nabi Biologics
CMC Acquires ICOS Biologics Operation
Roche Takes Over THP
GTC and LFB Commence CD20 Monoclonal Antibody Development
Amgen Inks Collaboration and License Pact with Daiichi Sankyo
CMC Biopharmaceuticals Inks Agreement with Morphotek
CMC Biopharmaceuticals Inks Agreement with Biotest
Eli Lilly Collaborates with MacroGenics
Genentech Inks Global Licensing Agreement with Seattle Genetics
6.MAJOR PLAYERS
Amgen, Inc. (US)
BD Biosciences (US)
Biogen Idec Inc (US)
Biotest AG (Germany)
CMC ICOS Biologics, Inc.
Dendreon Corporation (US)
Elan Corporations Plc (Ireland)
Eli Lilly and Company (US)
Genentech, Inc. (US)
Human Genome Sciences, Inc. (US)
Immunomedics, Inc. (US)
Johnson & Johnson (US)
Centocor (US)
Ortho Biotech Products, L.P. (US)
Medarex, Inc. (US)
MedImmune, Inc. (US)
PDL BioPharma (US)
Schering-Plough Corporation (US)
Strategic Diagnostics Inc (US)
UCB Group (Belgium)
Wyeth Pharmaceuticals (US)
7.MARKET ANALYTICS
8.THE UNITED STATES
Therapeutic Monoclonal Antibodies Market – An Overview
New Heights for US Cancer Therapeutics
Competitive Landscape
Leading Products
9.CANADA
10.JAPAN
11.EUROPE
a.France
b.Germany
c.Italy
d.The United Kingdom
e.Rest of Europe
12.REST OF WORLD
Australia
Australia is All Set to Meet the Increasing Demand
India
Exhibits
Table 1: Major Acquisitions of Antibody-Focused Companies –
Table 2: Market Shares of Leading Players in the Global Monoclonal Antibody Therapy Market –
Table 3: Market Shares of Leading Drugs in the Global Therapeutic Monoclonal Antibodies Market –
Table 4: Market Shares of Leading Antibody Based Products Manufacturers in the World –
Table 5: Market Shares of Leading Drugs in the Global Monoclonal Antibody Based Products Market –
Table 6: Market Shares of Leading Oncology Monoclonal Antibodies Products in the World – 2008E
Table 7: Market Shares of Leading Antibody-Based Anti-InflammatoryProducts in the World –
Table 8: Global Mab Market by Product Type –
Table 9: Market Shares of Monoclonal Antibody Therapies in the World – 2010E
Table 10: Global Market for Monoclonal Antibody Based Products by Region for the Period 2007-2015 (Sales in US$ Million)
Table 11: Percentage Breakdown of Global Market for Monoclonal Antibody Based Products by Region for the Years 2008 & 2009
Table 12: Global Therapeutics Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 13: Percentage Breakdown of Global Therapeutics Market by Region for the Years 2008 & 2009
Table 14: Global Therapeutic Monoclonal Antibody Based Products Market by Segments for the Period 2007- 2015 (Sales in US$ Million)
Table 15: Percentage Breakdown of Global Therapeutic Monoclonal Antibody Based Products Market by Segments for the Years 2008 & 2009
Table 16: Global Cancer Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 17: Percentage Breakdown of Global Cancer Market by Region for the Years 2008 & 2009
Table 18: Global Other Therapeutic Monoclonal Antibody Based Products Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 19: Percentage Breakdown of Global Other Therapeutic Monoclonal Antibody Based Products Market by Region for the Years 2008 & 2009
Table 20: Global Diagnostics Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 21: Percentage Breakdown of Global Diagnostics Market by Region for the Years 2008 & 2009
Table 22: Market Shares of Leading Therapeutic Monoclonal Antibodies Products in the US –
Table 23: Market Shares of Leading Therapeutic Monoclonal Antibodies Products Manufacturers in the US –
Table 24: Monoclonal Antibody Based Products Market by Segment in the US: 2007-2015 (Sales in US$ Million)
Table 25: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in the US for the Years 2008 & 2009
Table 26: Monoclonal Antibody Based Products Market by Segment in Canada: 2007-2015 (Sales in US$ Million)
Table 27: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Canada for the Years 2008 & 2009
Table 28: Monoclonal Antibody Based Products Market by Segment in Japan: 2007-2015 (Sales in US$ Million)
Table 29: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Japan for the Years 2008 & 2009
Table 30: Monoclonal Antibody Based Products Market by Region in Europe: 2007-2015 (Sales in US$ Million)
Table 31: Percentage Breakdown of Monoclonal Antibody Based Products Market by Region in Europe for the Years 2008 & 2009
Table 32: Monoclonal Antibody Based Products Market by Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 33: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Europe for the Years 2008 & 2009
Table 34: Monoclonal Antibody Based Products Market by Segment in France: 2007-2015 (Sales in US$ Million)
Table 35: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in France for the Years 2008 & 2009
Table 36: Monoclonal Antibody Based Products Market by Segment in Germany: 2007-2015 (Sales in US$ Million)
Table 37: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Germany for the Years 2008 & 2009
Table 38: Monoclonal Antibody Based Products Market by Segment in Italy: 2007-2015 (Sales in US$ Million)
Table 39: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Italy for the Years 2008 & 2009
Table 40: Monoclonal Antibody Based Products Market by Segment in the UK: 2007-2015 (Sales in US$ Million)
Table 41: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in the UK for the Years 2008 & 2009
Table 42: Monoclonal Antibody Based Products Market by Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
Table 43: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Rest of Europe for the Years 2008 & 2009
Table 44: Monoclonal Antibody Based Products Market by Segment in Rest of World: 2007-2015 (Sales in US$ Million)
Table 45: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Rest of World for the Years 2008 & 2009
Companies Profiled